News

Highmark Interactive Inc. Demonstrates Increased Traction in the Canadian Market with New Sport and Neurorehabilitation Customers

Highmark announces several wins building momentum in expanding their brain and mental health assessment technology footprint in sport and neurorehabilitation…

2 years ago

Pressure BioSciences, Inc. Reports Q1 2022 Financial Results

Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential…

2 years ago

CHU Toulouse in France Starts Liver and Lung Perfusion Programs Using XVIVO Technologies

GOTHENBURG, SWEDEN / ACCESSWIRE / May 19, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)The CHU Toulouse hospital in France…

2 years ago

Altamira Therapeutics to Present at the 2022 H.C. Wainwright Global Investment Conference

HAMILTON, BERMUDA / ACCESSWIRE / May 19, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…

2 years ago

Occlutech Signs Exclusive US Distribution Agreement with B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc.

SCHAFFHAUSEN, CH / ACCESSWIRE / May 19, 2022 / Occlutech Holding AGOcclutech Holding AG (Occlutech), a leading specialist provider of…

2 years ago

Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services

TAMPA, FL / ACCESSWIRE / May 19, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare…

2 years ago

TransCode Therapeutics Acquires Option for Radiotheranostic Technology

BOSTON, May 19, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer…

2 years ago

U.K. Member of Parliament Crispin Blunt To Inaugurate Psilocybin Cultivation Facility At Optimi Health Grand Opening

Blunt to speak on the importance of understanding psilocybin’s potential role in mental health, reducing barriers to continued research in…

2 years ago

Biora Therapeutics Announces New Patents for Targeted Therapeutics Platform

Marks 29 Patents Worldwide Directed to Biora’s Device Localization TechnologySAN DIEGO, May 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc.…

2 years ago

NeuroMetrix Reports that Quell® Wearable Neuromodulation Device has Received FDA De Novo Authorization as First Non-Pharmacological Treatment for Fibromyalgia

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced U.S. Food and Drug Administration (FDA)…

2 years ago